Pre-operative Nutrition for Elective Resection Surgery in Inflammatory Bowel Disease
Part of paid clinical trials in New York, New York.
- Sponsor
- NYU Langone Health
- Study ID
- NCT06309017
- Status
- Recruiting
Conditions
- Inflammatory Bowel Diseases
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Nutrition specialist — OTHERNutrition specialist to help improve nutritional status by diet, oral nutrition supplements or parenteral nutrition.
- Ensure Surgery Immunonutrition shakes — DIETARY_SUPPLEMENTAll study subjects, including subjects without malnutrition, will be given the Ensure Surgery Immunonutrition Shakes for prior to surgery as per standard of care. All subjects will also receive additional shakes starting as an inpatient when diet is advanced.
Study Details
This study aims to determine if improved risk stratification tools and interventions to mitigate malnutrition reduce postoperative risk in patients undergoing elective or emergent resection surgery for inflammatory bowel disease (IBD), and if adding immune modulation nutrition improves surgical outcomes. The primary objective is to assess whether preoperative malnutrition screening and intervention minimize postoperative complications. The secondary objective is to evaluate whether immune modulation nutrition in the peri-operative period decreases length of stay and major complications.
Key Dates
- Start date
- Jan 7, 2025
- Status verified
- Mar 2026
- Primary completion
- Jan 31, 2027
- Completion
- Jul 31, 2027
Study Design
- Enrollment
- 150 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Nutrition specialistParticipants will be assigned to this arm if the subject is determined malnourished. They will be sent to a nutrition specialist for a nutrition focused visit and will be provided standard of care intervention prior surgery.
- Active Comparator: Standard of CareParticipants that show no signs of malnutrition will be assigned to this arm. The subject will be provided with education and schedule of Ensure® Surgery Immunonutrition shakes for prior to surgery as per standard of care.
Primary Outcome Measure
Length of hospital stay [ Time Frame: Up to 30 days post-surgery ]
Central Contacts
- Jennifer Katz, MD(855) 698-4232
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| NYU Langone Health | New York | New York | 10016 | - |
Find similar trials in New York, NY
By research site
Related Studies
- Improving the Quality of Care for Adults With Inflammatory Bowel DiseaseEnrolling By Invitation · Dartmouth-Hitchcock Medical Center · Los Angeles, California
- A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)PHASE3 · Recruiting · Eli Lilly and Company · San Francisco, California
- Social Determinants of Health, Medication Use, and Quality of Life in Inflammatory Bowel DiseaseRecruiting · Montefiore Medical Center · New York, New York
- Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's DiseasePHASE3 · Recruiting · Weill Medical College of Cornell University · New York, New York